$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Ibrutinib/venetoclax combination outperforms ibrutinib and FCR alone in long-term CLL
2026-02-01 22:25:32
Check Details
Medical insurance reimbursement amount for ruxolitinib tablets/ruxolitinib
2026-02-01 22:25:32
Check Details
How long does it take to return to normal after taking clofazimine/sempra?
2026-02-01 22:25:32
Check Details
The maximum number of years of continuous use of Enasidenib
2026-02-01 22:25:32
Check Details
How long is a course of treatment with Evantumumab/Carestream?
2026-02-01 22:25:32
Check Details
Sebetralstat (Sebetralstat)-Ekterly instruction manual Chinese introduction
2026-02-01 22:25:32
Check Details
What are the requirements for medical insurance reimbursement of enzalutamide/enzalutamide?
2026-02-01 22:25:32
Check Details
What types of tumors are Sorafenib/Nexavar mainly used to treat?
2026-02-01 22:25:32
Check Details
What should I do if the price of pemetinib/pemetinib is too expensive?
2026-02-01 22:25:32
Check Details
The official Chinese name of Erdafitinib/Boct targeted drug
2026-02-01 22:25:32
Check Details
Comparison of the differences between Dacomitinib/Dozerun and Afatinib
2026-02-01 22:25:32
Check Details
Efficacy and effects of Sebetralstat-Ekterly
2026-02-01 22:25:32
Check Details
1
2
...
2021
2022
2023
2024
2025
2026
2027
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma